Global biotechnology leader CSL has reached a significant milestone with the European Medicines Agency’s (EMA) Committee for Medicinal Products...
Read MoreBerlin’s Diagnostisch Therapeutisches Zentrum (DTZ) has made history as the first facility in the world to treat a patient...
Read MoreMindMed has taken a significant step forward in the development of innovative treatments for Generalised Anxiety Disorder (GAD), announcing...
Read MoreBeckley Psytech has unveiled promising topline results from its Phase 2a study of ELE-101, a groundbreaking synthetic intravenous (IV)...
Read MoreMinoryx Therapeutics and Neuraxpharm Group have announced a significant breakthrough in the treatment of cerebral adrenoleukodystrophy (cALD) in paediatric...
Read MoreA groundbreaking new treatment for asthma and chronic obstructive pulmonary disease (COPD) could revolutionise how these life-threatening conditions are...
Read More